A. Rassi, . Jr, A. Rassi, and J. Marin-neto, Chagas disease, The Lancet, vol.375, issue.9723, pp.1388-1402, 2010.
DOI : 10.1016/S0140-6736(10)60061-X

P. Minoprio, S. Itohara, C. Heusser, S. Tonegawa, and A. Coutinho, Immunobiology of Murine T Cruzi Infection: The Predominance of Parasite-nonspecific Responses and the Activation of TCRIT Cells, Immunological Reviews, vol.19, issue.1, pp.183-207, 1989.
DOI : 10.1016/0092-8674(89)90674-0

W. Taliaferro and T. Pizzi, Connective Tissue Reactions in Normal and Immunized Mice to a Reticulotropic Strain of Trypanosoma Cruzi, Journal of Infectious Diseases, vol.96, issue.3, pp.199-226, 1955.
DOI : 10.1093/infdis/96.3.199

W. Savino, The Thymus Is a Common Target Organ in Infectious Diseases, PLoS Pathogens, vol.85, issue.6, p.62, 2006.
DOI : 0074-0276(1990)085[0255:TTMIID]2.0.CO;2

M. Tribulatti, J. Mucci, N. Van-rooijen, M. Leguizamón, and O. Campetella, The trans-Sialidase from Trypanosoma cruzi Induces Thrombocytopenia during Acute Chagas' Disease by Reducing the Platelet Sialic Acid Contents, Infection and Immunity, vol.73, issue.1, pp.201-207, 2005.
DOI : 10.1128/IAI.73.1.201-207.2005

E. De-titto and F. Araujo, Serum neuraminidase activity and hematological alterations in acute human Chagas' disease, Clinical Immunology and Immunopathology, vol.46, issue.1, pp.157-161, 1988.
DOI : 10.1016/0090-1229(88)90016-5

R. Schenkman, F. Vandekerckhove, and S. Schenkman, Mammalian cell sialic acid enhances invasion by Trypanosoma cruzi, Infect Immun, vol.61, pp.898-902, 1993.

S. Schenkman, M. Jiang, G. Hart, and V. Nussenzweig, A novel cell surface trans-sialidase of trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells, Cell, vol.65, issue.7, pp.1117-1125, 1991.
DOI : 10.1016/0092-8674(91)90008-M

S. Tomlinson, P. De-carvalho, L. Vandekerckhove, F. Nussenzweig, and V. , Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement, J Immunol, vol.153, pp.3141-3147, 1994.

V. Pereira-chioccola, A. Acosta-serrano, I. Correia-de-almeida, M. Ferguson, and T. Souto-padron, Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human antialpha-galactosyl antibodies, J Cell Sci, vol.113, pp.1299-1307, 2000.

J. Previato, A. Andrade, M. Pessolani, and L. Mendonca-previato, Incorporation of sialic acid into Trypanosoma cruzi macromolecules. A proposal for a new metabolic route, Molecular and Biochemical Parasitology, vol.16, issue.1, pp.85-96, 1985.
DOI : 10.1016/0166-6851(85)90051-9

S. Rubin-de-celis, H. Uemura, N. Yoshida, and S. Schenkman, Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole, Cellular Microbiology, vol.11, issue.12, pp.1888-1898, 2006.
DOI : 10.1126/science.2409595

R. Agusti, A. Couto, O. Campetella, A. Frasch, and R. De-lederkremer, The trans-sialidase of Trypanosoma cruzi is anchored by two different lipids, Glycobiology, vol.7, issue.6, pp.731-735, 1997.
DOI : 10.1093/glycob/7.6.731

P. Alvarez, C. Buscaglia, and O. Campetella, Improving Protein Pharmacokinetics by Genetic Fusion to Simple Amino Acid Sequences, Journal of Biological Chemistry, vol.279, issue.5, pp.3375-3381, 2004.
DOI : 10.1074/jbc.M311356200

M. Leguizamón, O. Campetella, G. Russomando, M. Almiron, and I. Guillen, Antibodies Inhibiting Trypanosoma cruzi Trans-Sialidase Activity In Sera From Human Infections, Journal of Infectious Diseases, vol.170, issue.6, pp.1570-1574, 1994.
DOI : 10.1093/infdis/170.6.1570

M. Leguizamón, E. Mocetti, G. Rivello, H. Argibay, P. Campetella et al., Induces Apoptosis in Cells from the Immune System In Vivo, The Journal of Infectious Diseases, vol.180, issue.4, pp.1398-1402, 1999.
DOI : 10.1086/315001

M. Risso, T. Pitcovsky, R. Caccuri, O. Campetella, and M. Leguizamón, Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections, Parasitology, vol.62, issue.04, pp.503-510, 2007.
DOI : 10.1111/j.1462-5822.2006.00689.x

J. Mucci, A. Hidalgo, E. Mocetti, P. Argibay, and M. Leguizamón, -sialidase-induced apoptosis on nurse cells complex, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3896-3901, 2002.
DOI : 10.1073/pnas.052496399
URL : https://hal.archives-ouvertes.fr/hal-01392323

M. Chuenkova and M. Pereira, Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease, Journal of Experimental Medicine, vol.181, issue.5, pp.1693-1703, 1995.
DOI : 10.1084/jem.181.5.1693

M. Risso, G. Garbarino, E. Mocetti, O. Campetella, G. Cappa et al., Phylogenetic Lineages, The Journal of Infectious Diseases, vol.189, issue.12, pp.2250-2259, 2004.
DOI : 10.1086/420831

M. Munoz, L. Murcia, and M. Segovia, The urgent need to develop new drugs and tools for the treatment of Chagas disease, Expert Review of Anti-infective Therapy, vol.9, issue.1, pp.5-7, 2011.
DOI : 10.1586/eri.10.144

S. Wilkinson, M. Taylor, D. Horn, J. Kelly, and I. Cheeseman, A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes, Proceedings of the National Academy of Sciences, vol.105, issue.13, pp.5022-5027, 2008.
DOI : 10.1073/pnas.0711014105

A. Buschiazzo, G. Tavares, O. Campetella, S. Spinelli, and M. Cremona, Structural basis of sialyltransferase activity in trypanosomal sialidases, The EMBO Journal, vol.19, issue.1, pp.16-24, 2000.
DOI : 10.1093/emboj/19.1.16

A. Buschiazzo, M. Amaya, M. Cremona, A. Frasch, and P. Alzari, The Crystal Structure and Mode of Action of Trans-Sialidase, a Key Enzyme in Trypanosoma cruzi Pathogenesis, Molecular Cell, vol.10, issue.4, pp.757-768, 2002.
DOI : 10.1016/S1097-2765(02)00680-9

J. Neres, M. Brewer, L. Ratier, H. Botti, and A. Buschiazzo, Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.3, pp.589-596, 2009.
DOI : 10.1016/j.bmcl.2008.12.065

J. Neres, R. Bryce, and K. Douglas, Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease, Drug Discovery Today, vol.13, issue.3-4, pp.110-117, 2008.
DOI : 10.1016/j.drudis.2007.12.004

S. Buchini, A. Buschiazzo, and S. Withers, A New Generation of SpecificTrypanosoma cruzi trans-Sialidase Inhibitors, Angewandte Chemie International Edition, vol.124, issue.14, pp.2700-2703, 2008.
DOI : 10.1002/anie.200705435

T. Pitcovsky, C. Buscaglia, J. Mucci, and O. Campetella, ???Sialidase, The Journal of Infectious Diseases, vol.186, issue.3, pp.397-404, 2002.
DOI : 10.1086/341463

T. Pitcovsky, J. Mucci, P. Alvarez, M. Leguizamón, and O. Burrone, Epitope Mapping of trans-Sialidase from Trypanosoma cruzi Reveals the Presence of Several Cross-Reactive Determinants, Infection and Immunity, vol.69, issue.3, pp.1869-1875, 2001.
DOI : 10.1128/IAI.69.3.1869-1875.2001

M. Leguizamón, G. Russomando, A. Luquetti, A. Rassi, and M. Almiron, -Sialidase Inhibition Assay of Sera from Parasite-Free, Serologically Cured Chagasic Patients, The Journal of Infectious Diseases, vol.175, issue.5, pp.1272-1275, 1997.
DOI : 10.1086/593697

O. Campetella, D. Sánchez, J. Cazzulo, and A. Frasch, A superfamily of trypanosoma cruzi surface antigens, Parasitology Today, vol.8, issue.11, pp.378-381, 1992.
DOI : 10.1016/0169-4758(92)90175-2

M. Cremona, O. Campetella, D. Sanchez, and A. Frasch, Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display ??-galactose binding activity, Glycobiology, vol.9, issue.6, pp.581-587, 1999.
DOI : 10.1093/glycob/9.6.581

M. Cremona, D. Sanchez, A. Frasch, and O. Campetella, A single tyrosine differentiates active and inactive Trypanosoma cruzi trans-sialidases, Gene, vol.160, issue.1, pp.123-128, 1995.
DOI : 10.1016/0378-1119(95)00175-6

A. Watts, I. Damager, M. Amaya, A. Buschiazzo, and P. Alzari, Trans-sialidase Operates through a Covalent Sialyl???Enzyme Intermediate:?? Tyrosine Is the Catalytic Nucleophile, Journal of the American Chemical Society, vol.125, issue.25, pp.7532-7533, 2003.
DOI : 10.1021/ja0344967

C. Buscaglia, O. Campetella, M. Leguizamón, and A. Frasch, -Sialidase Enhances the Immune Response against the Catalytic Domain, The Journal of Infectious Diseases, vol.177, issue.2, pp.431-436, 1998.
DOI : 10.1086/514199
URL : https://hal.archives-ouvertes.fr/hal-00946915

L. Powell and G. Hart, Quantitation of picomole levels of N-acetyl- and N-glycolylneuraminic acids by a HPLC-adaptation of the thiobarbituric acid assay, Analytical Biochemistry, vol.157, issue.1, pp.179-185, 1986.
DOI : 10.1016/0003-2697(86)90211-3

R. Muiá, H. Yu, J. Prescher, U. Hellman, and X. Chen, Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation, Glycobiology, vol.20, issue.7, pp.833-842, 2010.
DOI : 10.1093/glycob/cwq037

E. Blanc, P. Roversi, C. Vonrhein, C. Flensburg, and S. Lea, Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT, 2004.

P. Emsley and K. Cowtan, : model-building tools for molecular graphics, Acta Crystallographica Section D Biological Crystallography, vol.60, issue.12, pp.2126-2132, 2004.
DOI : 10.1107/S0907444904019158

O. Smart, M. Brandl, C. Flensburg, P. Keller, and W. Paciorek, Refinement with Local Structure Similarity Restraints (LSSR) Enables Exploitation of Information from Related Structures and Facilitates use of NCS, 2008.

D. Davies, E. Padlan, and S. Sheriff, Antibody-Antigen Complexes, Annual Review of Biochemistry, vol.59, issue.1, pp.439-473, 1990.
DOI : 10.1146/annurev.bi.59.070190.002255

M. Lawrence and P. Colman, Shape Complementarity at Protein/Protein Interfaces, Journal of Molecular Biology, vol.234, issue.4, pp.946-950, 1993.
DOI : 10.1006/jmbi.1993.1648

J. Mucci, M. Risso, M. Leguizamón, A. Frasch, and O. Campetella, The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation, Cellular Microbiology, vol.2, issue.7, pp.1086-1095, 2006.
DOI : 10.1093/glycob/cwh123

R. Webster, P. Reay, and W. Laver, Protection against lethal influenza with neuraminidase, Virology, vol.164, issue.1, pp.230-237, 1988.
DOI : 10.1016/0042-6822(88)90640-X

M. Stumpp, H. Binz, and P. Amstutz, DARPins: A new generation of protein therapeutics, Drug Discovery Today, vol.13, issue.15-16, pp.695-701, 2008.
DOI : 10.1016/j.drudis.2008.04.013

P. Holliger and P. Hudson, Engineered antibody fragments and the rise of single domains, Nature Biotechnology, vol.10, issue.9, pp.1126-1136, 2005.
DOI : 10.1182/blood-2005-03-1153

A. Natarajan and S. Denardo, PEGylation of Antibody Fragments to Improve Pharmacodynamics and Pharmacokinetics, Antibody Engineering. 2 ed, 2010.
DOI : 10.1007/978-3-642-01147-4_15

L. Venkatramani, E. Bochkareva, J. Lee, U. Gulati, G. Laver et al., An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA???Antibody Complex, Journal of Molecular Biology, vol.356, issue.3, pp.651-663, 2006.
DOI : 10.1016/j.jmb.2005.11.061

W. Tulip, J. Varghese, W. Laver, R. Webster, and P. Colman, Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex, Journal of Molecular Biology, vol.227, issue.1, pp.122-148, 1992.
DOI : 10.1016/0022-2836(92)90687-F

W. Tulip, J. Varghese, R. Webster, W. Laver, and P. Colman, Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface, Journal of Molecular Biology, vol.227, issue.1, pp.149-159, 1992.
DOI : 10.1016/0022-2836(92)90688-G

R. Malby, W. Tulip, V. Harley, J. Mckimm-breschkin, and W. Laver, The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody, Structure, vol.2, issue.8, pp.733-746, 1994.
DOI : 10.1016/S0969-2126(00)00074-5

U. Gulati, C. Hwang, L. Venkatramani, S. Gulati, and S. Stray, Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98), Journal of Virology, vol.76, issue.23, pp.12274-12280, 2002.
DOI : 10.1128/JVI.76.23.12274-12280.2002

M. Amaya, A. Buschiazzo, T. Nguyen, and P. Alzari, The High Resolution Structures of Free and Inhibitor-bound Trypanosoma rangeli Sialidase and its Comparison with T.cruziTrans-sialidase, Journal of Molecular Biology, vol.325, issue.4, pp.773-784, 2003.
DOI : 10.1016/S0022-2836(02)01306-2

N. Cohen, Structure-Based Drug Design and the Discovery of Aliskiren (Tekturna??): Perseverance and Creativity to Overcome a R&D Pipeline Challenge???, Chemical Biology & Drug Design, vol.7, issue.6, pp.557-565, 2007.
DOI : 10.1111/j.1747-0285.2007.00599.x

A. Buschiazzo, A. Frasch, and O. Campetella, Medium scale production and purification to homogeneity of a recombinant trans-sialidase from Trypanosoma cruzi, Cell Mol Biol, vol.42, pp.703-710, 1996.

F. Frank, P. Petray, S. Cazorla, M. Munoz, and R. Corral, Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes, Vaccine, vol.22, issue.1, pp.77-86, 2003.
DOI : 10.1016/S0264-410X(03)00541-3

J. Goding, Monoclonal antibodies: principles and practices, 1996.

A. Leslie, Molecular data processing, Crystallographic computing, 1990.

A. Mccoy, R. Grosse-kunstleve, P. Adams, M. Winn, and L. Storoni, crystallographic software, Journal of Applied Crystallography, vol.40, issue.4, pp.658-674, 2007.
DOI : 10.1107/S0021889807021206

V. Chen, W. Arendall, J. Headd, D. Keedy, and R. Immormino, : all-atom structure validation for macromolecular crystallography, Acta Crystallographica Section D Biological Crystallography, vol.285, issue.1, pp.12-21, 2010.
DOI : 10.1107/S0907444909042073
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803126